Follow
Amir Zarebkohan
Amir Zarebkohan
Medical Nanotechnology Ph.D, Tabriz University of Medical Sciences
Verified email at tbzmed.ac.ir
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
98692021
Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells
M Ghaffari, G Dehghan, B Baradaran, A Zarebkohan, B Mansoori, ...
Colloids and Surfaces B: Biointerfaces 188, 110762, 2020
1402020
Exosomal delivery of therapeutic modulators through the blood–brain barrier; promise and pitfalls
M Heidarzadeh, Y Gürsoy-Özdemir, M Kaya, A Eslami Abriz, ...
Cell & Bioscience 11, 1-28, 2021
1222021
Significant role of cationic polymers in drug delivery systems
M Farshbaf, S Davaran, A Zarebkohan, N Annabi, A Akbarzadeh, ...
Artificial cells, nanomedicine, and biotechnology 46 (8), 1872-1891, 2018
1082018
Targeted drug delivery based on gold nanoparticle derivatives
M Gholipourmalekabadi, M Mobaraki, M Ghaffari, A Zarebkohan, ...
Current pharmaceutical design 23 (20), 2918-2929, 2017
1002017
Smart and biomimetic 3D and 4D printed composite hydrogels: opportunities for different biomedical applications
S Malekmohammadi, N Sedghi Aminabad, A Sabzi, A Zarebkohan, ...
Biomedicines 9 (11), 1537, 2021
852021
Cell surface GRP78: An emerging imaging marker and therapeutic target for cancer
M Farshbaf, AY Khosroushahi, S Mojarad-Jabali, A Zarebkohan, ...
Journal of Controlled Release 328, 932-941, 2020
852020
Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by SRL peptide for targeted gene delivery to the brain
A Zarebkohan, F Najafi, HR Moghimi, M Hemmati, MR Deevband, ...
European Journal of Pharmaceutical Sciences 78, 19-30, 2015
852015
The impact of protein corona on the biological behavior of targeting nanomedicines
M Farshbaf, H Valizadeh, Y Panahi, Y Fatahi, M Chen, A Zarebkohan, ...
International Journal of Pharmaceutics 614, 121458, 2022
722022
Crosstalk between chitosan and cell signaling pathways
B Farhadihosseinabadi, A Zarebkohan, M Eftekhary, M Heiat, ...
Cellular and Molecular Life Sciences 76, 2697-2718, 2019
652019
Protein corona and exosomes: new challenges and prospects
M Heidarzadeh, A Zarebkohan, R Rahbarghazi, E Sokullu
Cell Communication and Signaling 21 (1), 64, 2023
612023
Advanced bioresponsive multitasking hydrogels in the new era of biomedicine
M Niazi, E Alizadeh, A Zarebkohan, K Seidi, MH Ayoubi‐Joshaghani, ...
Advanced Functional Materials 31 (41), 2104123, 2021
612021
AS1411 aptamer-functionalized chitosan-silica nanoparticles for targeted delivery of epigallocatechin gallate to the SKOV-3 ovarian cancer cell lines
L Alizadeh, E Alizadeh, A Zarebkohan, E Ahmadi, M Rahmati-Yamchi, ...
Journal of Nanoparticle Research 22, 1-14, 2020
582020
Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers
M Farshbaf, S Mojarad-Jabali, S Hemmati, AY Khosroushahi, ...
Journal of Controlled Release 345, 371-384, 2022
452022
Cytotoxicity characteristics of green assisted-synthesized superparamagnetic maghemite (γ-Fe2O3) nanoparticles
A Bali Ogholbeyg, A Kianvash, A Hajalilou, E Abouzari-Lotf, ...
Journal of Materials Science: Materials in Electronics 29, 12135-12143, 2018
402018
Chitosan-based nanotherapeutics for ovarian cancer treatment
L Alizadeh, A Zarebkohan, R Salehi, A Ajjoolabady, M Rahmati-Yamchi
Journal of drug targeting 27 (8), 839-852, 2019
382019
Targeted co-delivery of curcumin and doxorubicin by citric acid functionalized Poly (ε-caprolactone) based micelle in MDA-MB-231 cell
A Sabzi, A Rahmani, M Edalati, H Kahroba, MR Dadpour, R Salehi, ...
Colloids and Surfaces B: Biointerfaces 194, 111225, 2020
362020
Nonordered dendritic mesoporous silica nanoparticles as promising platforms for advanced methods of diagnosis and therapies
S Malekmohammadi, RUR Mohammed, H Samadian, A Zarebkohan, ...
Materials Today Chemistry 26, 101144, 2022
352022
An update on dual targeting strategy for cancer treatment
YD Taghipour, A Zarebkohan, R Salehi, F Rahimi, VP Torchilin, ...
Journal of Controlled Release 349, 67-96, 2022
342022
Co-delivery of doxorubicin and conferone by novel pH-responsive β-cyclodextrin grafted micelles triggers apoptosis of metastatic human breast cancer cells
A Rahmani, F Rahimi, M Iranshahi, H Kahroba, A Zarebkohan, M Talebi, ...
Scientific Reports 11 (1), 21425, 2021
312021
The system can't perform the operation now. Try again later.
Articles 1–20